Refractory Ascites: Clinical Trials

2 trials for Refractory Ascites, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2

Follow Refractory Ascites: new trials by email Literature Review of Refractory Ascites trials Research Report on Refractory Ascites

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
L-ornithine-L-aspartate - Decompensated Cirrhosis, Portal Hypertension
Phase 2 / Phase 3CompletedAir Force Military Medical University, China402011-12-012012-12-19
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Midodrine, albumin, octreotide LAR, midodrine, octreotide, albumin - Type 2 Hepatorenal Syndrome, Refractory Ascites
Phase 2 / Phase 3CompletedUniversity of Alberta92005-10-012007-12-06

Narrower conditions

Ascites (2)  ·  Fibrosis (1)  ·  Hepatorenal Syndrome (1)  ·  Hypertension, Portal (1)  ·  Liver Cirrhosis (1)

Broader conditions

Digestive System Diseases (2)  ·  Liver Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fibrosis (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Albumins (1)  ·  Midodrine (1)  ·  Octreotide (1)  ·  ornithylaspartate (1)

Sponsors

Air Force Military Medical University, China (1)  ·  University of Alberta (1)

Countries

Canada (1)  ·  China (1)

Top investigators

Guohong Han, PhD & MD (1)  ·  Vincent Bain, MD, FRCPC (1)